Tocilizumab: The Key to Stop Coronavirus Disease 2019 (COVID-19)-Induced Cytokine Release Syndrome (CRS)?

Tocilizumab: The Key to Stop Coronavirus Disease 2019 (COVID-19)-Induced Cytokine Release Syndrome (CRS)?

The COVID-19 disease is an unprecedented international public health emergency and considerably impacts the global economy and health service system. While awaiting the development of an effective vaccine, searching for the therapy for severe or critical COVID-19 patients is essential for reducing t...

Full description

Bibliographic Details
Main Authors: Danfei Liu, Tongyue Zhang, Yijun Wang, Limin Xia
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-10-01
Series:Frontiers in Medicine
Subjects:
COVID-19
cytokine release syndrome
interleukin-6
tocilizumab
SARS-CoV-2
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2020.571597/full

Similar Items

Similar Items